3738521
Degradable PEG-lipids for lipid nanoparticle mRNA formulation
Date
August 23, 2022
Related Products
Activating innate anti-tumor immune killing by antibody-recruiting hapten-lipid dendrimers
Exploiting innate immune effector mechanisms against the Fc domain of monoclonal antibodies (mAbs) is gaining immense popularity in anti-cancer therapy…
A novel library of degradable ionizable lipids for mRNA immunotherapy
Intracellular delivery of mRNA represents one of the greatest challenges due to the fragility of mRNA and the difficulty to destabilize the endosomal membrane. One of the most advanced non-viral delivery systems for mRNA are lipid nanoparticles (LNPs)…
Light-Stabilised Dynamic Materials at the Macro-, Micro- and Nanoscale: Breaking covalent bonds with the mildest trigger of all?
The ability of photoswitches to reversibly undergo a photochemical response continues to highly impact the field of materials science, most notably in the design of molecular machines that can undergo translational or rotary motion that is fuelled by light…
Lipid-PEG-fentanyl bio-conjugates as a hapten design for lipid nanoparticle templated anti-fentanyl vaccines
The opioid use disorder epidemic is ravaging the western society, with high rates of relapse and overdose deaths. Anti-opioid vaccines could reduce long-term opioid (ab)use and the risk of accidental overdose…